NCT05662293Recruiting
Characterization of Arrhythmia-induced Cardiomyopathy
Arrhythmia-induced Cardiomyopathy - a Prospective Observational Cohort Study
Source: ClinicalTrials.gov · Last updated 4 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of the this observational study is to gather clinically available data on patients presenting with a suspicion for arrhythmia-induced cardiomyopathy (AiCM) at the University Hospital Basel.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2700 (estimated)
- First submitted
- 14 Dec 2022
- Start date
- 10 Jun 2021
- Primary completion date
- Jan 2026
- Lead sponsor
- University Hospital, Basel, Switzerland
- Diseases
- Atrial fibrillation
- NCT number
- NCT05662293
What you commit to
- Study type: Observational
- Planned participants: 2700
- From 10 Jun 2021 to the primary completion date, Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Temporary exclusion criteria: Acute health condition such as myocardial infarction, patients presenting with a major trauma, a sepsis, patients shortly after cardiac surgery, and patients in shock (\>100 bpm, \<90 systolic BP, evidence of organ dysfunction).
- Life expectancy \<1 year (palliative, terminal cancer)
- Retrospective part
- Patients with life expectancy \<1 year (palliative, terminal cancer)
Lab values
- Acute event clearly leading to an acutely reduced LVEF (massive type I myocardial infarction, cardiogenic shock from a coronary or myocardial etiology, septic shock leading to toxic myopathy, hypovolemic shock with reduced EF, cardiac arrest and/or need for resuscitation).
Age
- Age \<18 years old
- Age \< 18 years old
Other
- Patient's active refusal of the general consent of the University Hospital Basel
- Patient's active refusal of the general consent of the University Hospital Basel
Who the study is looking for
- Diagnostic or suspicion of AiCM as presence of specified keyword in patient's file or as screened by colleagues of the internal medicine or cardiology clinics
- Signed study consent
- Patients with a reduced left-ventricular ejection fraction (LVEF ≤50%) or a reduction of 15% in the ejection fraction (EF) between two echocardiographies and a concomitant diagnosis of any arrhythmia likely to lead to AiCM within one year before or after diagnosis of the reduced LVEF from 2010-2021
Criteria the registry did not label
- Prospective part
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Basel, Department of Cardiology Coordinator of this site? Confirm its status | Basel | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.